Viewing Study NCT03656094


Ignite Creation Date: 2025-12-25 @ 1:40 AM
Ignite Modification Date: 2026-01-03 @ 7:08 PM
Study NCT ID: NCT03656094
Status: UNKNOWN
Last Update Posted: 2019-12-09
First Post: 2018-07-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Chemotherapy With Pembrolizumab Continuation After Progression to PD-1/L1 Inhibitors
Sponsor: Samsung Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module